Anika Therapeutics (ANIK) Tax Provisions (2010 - 2026)
Anika Therapeutics (ANIK) reported Tax Provisions of $235000.0 for Q1 2026, up 135.0% year-over-year from $100000.0 in Q1 2025, and up 122.86% quarter-over-quarter from -$1.0 million in Q4 2025.
Anika Therapeutics (ANIK) Tax Provisions (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 17 years of Tax Provisions data on file, last reported at $235000.0 in Q1 2026.
- Tax Provisions for Q1 2026 came in at $235000.0, up 135.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $827000.0 (down 86.56% YoY), and the FY2025 annual result was $672000.0, down 88.92% from the prior year.
- Tax Provisions grew to $235000.0 in Q1 2026 per ANIK's latest filing, from -$1.0 million in the prior quarter.
- Over five years, Tax Provisions peaked at $8.2 million in Q4 2023 and troughed at -$1.7 million in Q1 2023.
- A 5-year average of $995764.7 and a median of $100000.0 in 2025 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2024: Tax Provisions slumped 272.91% in 2022, then surged 542.0% in 2024.
- A 5-year view of Tax Provisions shows it stood at $6.6 million in 2022, then rose by 23.76% to $8.2 million in 2023, then slumped by 69.13% to $2.5 million in 2024, then sank by 140.71% to -$1.0 million in 2025, then soared by 122.86% to $235000.0 in 2026.
- Business Quant data shows ANIK's Tax Provisions at $235000.0 in Q1 2026, -$1.0 million in Q4 2025, and $939000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 67.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 157.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -3.57 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 48.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 30.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.60 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -9.44 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 37.99 Mn |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn | 235,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235,000.00 |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | 939,000.00 |
| Jun 30, 2025 | 681,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 2.53 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 8.18 Mn |
| Sep 30, 2023 | -500,000.00 |
| Jun 30, 2023 | -300,000.00 |
| Mar 31, 2023 | -1.66 Mn |
| Dec 31, 2022 | 6.61 Mn |
| Sep 30, 2022 | -1.20 Mn |
| Jun 30, 2022 | -442,000.00 |
| Mar 31, 2022 | -775,000.00 |
| Dec 31, 2021 | -3.38 Mn |
| Sep 30, 2021 | 694,000.00 |
| Jun 30, 2021 | 2.60 Mn |